| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 10 Nov 2026 | 10-Q |
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
Launched new corporate brand as AchieveRx, The Quit Company (Nasdaq: QUIT) |
| 06 Oct 2026 |
Form 4: Halladay Benjamin, Chief Financial Officer
Granted 200,000 Stock Option (right to buy) · Granted 200,000 Restricted Stock Unit (RSU) |
| 06 Oct 2026 |
Form 3: Halladay Benjamin, Chief Financial Officer
No securities owned |
| 01 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On October 1, 2026, Achieve Life Sciences, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Benjamin Halladay as the Company’s Chief Financial Officer and “principal financial officer,” ef... |
| 21 Aug 2026 |
Form 4: Stewart Richard Alistair, Director
Sold 20,626 shares ($175K) |
| 19 Aug 2026 | 144 |
| 17 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 |
8-K: Other Events
Achieve Life Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent (the “Agent”), shares of the Comp... |
| 14 Aug 2026 | 424B5 |
| 13 Aug 2026 | SCHEDULE 13G |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million from warrants exercisable prior to and up to 20 trading days following FDA approval |
| 29 Jul 2026 |
Form 4: Royston Aaron, Director
Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU) |
| 29 Jul 2026 |
Form 4: Sellig Thomas, Director
Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU) |
| 29 Jul 2026 |
Form 4: Martin Christopher Nathan, Director
Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU) |
| 29 Jul 2026 |
Form 4: Waldman Reid Alexander, Director
Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU) |
| 29 Jul 2026 |
Form 4: Stewart Richard Alistair, Director
Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU) |
| 29 Jul 2026 |
Form 4: Farrow Jeffrey S, Director
Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU) |
Loading...